Your selection
Research, Innovation, Patient care, Education / 18.09.2025
Talk in the Cube: IP STRATEGIES IN BIOTECHNOLOGY
We are excited to continue the Talks in the Cube with an expert discussion focused on Strategies for Intellectual Property Rights in Biotechnology.
Effective strategies for Intellectual Property (IP) in Biotechnology include using patents for new processes and products, applying trade secrets for complex bioengineering methods, and employing trademarks for branding. A comprehensive strategy also means building adequate patent portfolios through patent jungles or "Biobetters", monitoring and defending IP rights against infringement, and potentially using licensing agreements for technology transfer.
Our two esteemed experts who are trained natural scientists AND European Patent Attorneys. They will share their insights and experiences with us.
A Panel Discussion with
Dr. Sun Jin Lee, European Patent Attorney, European Patent Litigator (UPC), Maiwald GmbH, Munich
Dr. Oliver Ladendorf, LL.B., European Patent Attorney, Kraus & Lederer PartGmbH, Munich
Dr. Uwe Lohmeier, Berlin BioScience Academy (BBA), Campus Berlin Buch GmbH (Moderation).
Topics planned to be addressed
- Smart patenting for Biotech: Portfolios providing leverage and attracting investors
- Licensing of innovative technologies: Patents for organoids and CRISPR/Cas
- Biotech Patents and AI: Examples to influence innovations and to protect data-driven discoveries.
The talk will be followed by a networking event where you can socialize over snacks and drinks.
Target audience
Founders & scientists from start-ups, small and medium-sized life science companies and scientific institutions.
Costs
Participation is free of charge. Registration is requested.
When
Thursday, 18 September 2025
5:00 p.m. - 7:00 p.m.
Where
BerlinBioCube (Building D95), Campus Berlin-Buch, Robert-Rössle-Straße 10, 13125 Berlin
Quelle: BerlinBioscience Academy
Further information and registration
Overview News
News Buch Berlin
T-knife Therapeutics Presents Preclinical Data on PRAME-Targeted TK-6302 Highlighting its Potential as a Promising, Category-leading Therapy
Comprehensive TK-6302 data demonstrate preclinical efficacy and safety, supporting clinical readiness, alongside established scalable manufacturing. TK-6302 Clinical Trial Application planned in Q4 20...
more ...Why APOE4 raises Alzheimer’s risk
Researchers at the Max Delbrück Center and Aarhus University have found a mechanism through which the gene variant APOE4, long linked to a high risk of developing Alzheimer’s disease, impairs neuronal...
more ...A potential new drug for stiff hearts
Michael Gotthardt at the Max Delbrück Center and collaborators are developing a drug to treat a common type of heart failure characterized by impaired cardiac filling. In “Cardiovascular Research,” hi...
more ...Events Buch Berlin
16.11.2025, 11:00
Kinderkonzert zu Vivaldis "Vier Jahreszeiten"
Das Kammerensemble der Bürgersinfonie lädt Kinder zum Zuhören, Mitmachen und Instrumente-Ausprobieren ein.
more ...16.11.2025, 15:00
Konzert der Bürgersinfonie: "Vier Jahreszeiten" von Vivaldi
Das Kammerensemble der Bürgersinfonie wird sie mit Texten und der wunderbaren Musik von Antonio Vivaldi durch die Jahreszeiten führen.
more ...21.11.2025, 19:00
Der Jeanne Mammen Salon „ein herrlicher Schatz“
Anlässlich des 135. Geburtstags der Berliner Künstlerin lassen wir am 21. November 2025 ab 19:00 Uhr im Jeanne Mammen Saal im Torhaus des Campus Berlin-Buch die Tradition der Berliner Salonabende mit ...
more ...